CINECA IRIS Institutional Research Information System

PALERMO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.436
EU - Europa 814
AS - Asia 366
AF - Africa 66
OC - Oceania 3
Totale 2.685
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.426
IT - Italia 300
SE - Svezia 192
SG - Singapore 149
CN - Cina 138
DE - Germania 88
AT - Austria 72
BG - Bulgaria 67
CI - Costa d'Avorio 43
VN - Vietnam 29
GB - Regno Unito 22
TR - Turchia 19
PL - Polonia 17
IN - India 15
SN - Senegal 15
CA - Canada 10
FR - Francia 10
HK - Hong Kong 10
IE - Irlanda 8
NL - Olanda 7
ES - Italia 6
FI - Finlandia 6
RU - Federazione Russa 6
CZ - Repubblica Ceca 5
NG - Nigeria 5
AU - Australia 3
BE - Belgio 2
JP - Giappone 2
MA - Marocco 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
EG - Egitto 1
GR - Grecia 1
IL - Israele 1
IM - Isola di Man 1
LT - Lituania 1
NO - Norvegia 1
UA - Ucraina 1
Totale 2.685
Salva come PNG Salva come JPEG
Città #
Fairfield 174
Chandler 165
Woodbridge 115
Ashburn 86
Singapore 78
Houston 77
Milan 77
Seattle 76
Wilmington 73
New York 71
Vienna 69
Santa Clara 68
Sofia 67
Boardman 58
Frankfurt am Main 49
Cambridge 46
Abidjan 43
Princeton 41
Florence 40
Lawrence 35
Beijing 30
Pisa 30
Serra 29
Medford 28
Ann Arbor 25
Guangzhou 21
Bremen 17
Istanbul 17
Trieste 17
Warsaw 16
Dakar 15
Ogden 15
San Diego 13
Rome 12
Fuzhou 11
Shanghai 11
Boulder 10
Hong Kong 10
London 9
Dong Ket 8
La Spezia 7
Des Moines 6
Ottawa 6
Palaia 6
San Francisco 6
Brno 5
Lagos 5
Los Angeles 5
Munich 5
Cascina 4
Dallas 4
Galway 4
Hebei 4
Hyderabad 4
Massa E Cozzile 4
Norwalk 4
Quanzhou 4
Dearborn 3
Harbin 3
Helsinki 3
Jiaxing 3
Kochi 3
Manacor 3
Moscow 3
Nanjing 3
Newcastle upon Tyne 3
Redwood City 3
Rho 3
Urbana 3
Washington 3
Agadir 2
Amsterdam 2
Barcelona 2
Brussels 2
Burlington 2
Calgary 2
Canberra 2
Carrara 2
Dublin 2
Genova 2
Haikou 2
Kaluga 2
Kostroma 2
Lyon 2
Manchester 2
Maynooth 2
Naples 2
Palermo 2
Pontedera 2
Romainville 2
Rourkela 2
Sheffield 2
Shenzhen 2
Utrecht 2
Vicopisano 2
Albany 1
Asyut 1
Baotou 1
Bergen 1
Bologna 1
Totale 2.029
Salva come PNG Salva come JPEG
Nome #
Antipsychotic drugs in Huntington's disease 118
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 111
Advances in the pharmacotherapeutic management of dementia with Lewy bodies 108
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 106
A frontline defense against neurodegenerative diseases:the development of early disease detection methods 105
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition 102
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases 100
Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD 97
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development 91
Freezing of gait and dementia in parkinsonism: A retrospective case–control study 88
null 86
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 84
Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease 80
Impact of COVID-19 pandemic on cognition in Parkinson's disease 77
Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome 76
Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study 76
Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study 71
Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis 67
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease 65
Molecular Imaging of the Dopamine Transporter 58
Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments 57
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 54
Theory of mind in Parkinson’s disease: evidences in drug-naïve patients and longitudinal effects of dopaminergic therapy 52
Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases 52
Prevalence and clinical correlates of comorbid anxiety and panic disorders in patients with Parkinson’s disease 52
Dissecting the Interplay between Time of Dementia and Cognitive Profiles in Lewy Body Dementias 52
Future avenues for Alzheimer's disease detection and therapy: Liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery 49
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 47
Dopamine transporter imaging, current status of a potential biomarker: A comprehensive review 44
β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification 42
Understanding the Multiple Role of Mitochondria in Parkinson’s Disease and Related Disorders: Lesson From Genetics and Protein–Interaction Network 41
Understanding the Multiple Role of Mitochondria in Parkinson’s Disease and Related Disorders: Lesson From Genetics and Protein–Interaction Network 40
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies 39
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 39
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 37
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 37
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases 37
Negative DAT-SPECT in Old Onset Parkinson's Disease: An Additional Pitfall? 28
SLC25A46 mutations in patients with Parkinson's Disease and optic atrophy 25
Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy 20
Two cases of Huntington's disease unmasked by the COVID-19 pandemic 19
Early Compensatory Mechanisms in LRRK2 Mutation Carriers 14
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints 14
Perampanel as a novel treatment for subcortical myoclonus in myoclonus-dystonia syndrome 14
Prokineticin-2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients 13
Neurogenic orthostatic hypotension in Parkinson's disease: is there a role for locus coeruleus magnetic resonance imaging? 12
Expanding Glucocerebrosidase Involvement in Neurodegeneration: D419H Mutation Causing Dementia with Lewy Bodies 12
Supplementing Best Care with Specialized Rehabilitation Treatment in Parkinson’s Disease: A Retrospective Study by Different Expert Centers 12
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease 11
Statins in Parkinson's Disease: Influence on Motor Progression 10
Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies 10
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease 9
Essential tremor and cognitive impairment: who, how, and why 8
Clues to Reshaping Anti-α-Synuclein Immunotherapy in Early Parkinson's Disease Patients 8
Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson's Disease 8
Mild Cognitive Impairment in de novo Parkinson's Disease: Selective Attention Deficit as Early Sign of Neurocognitive Decay 7
Dominant VPS16 Pathogenic Variants: Not Only Isolated Dystonia 6
Family History in Parkinson's Disease: A National Cross-Sectional Study 3
Mitochondrial Parkinsonism: A Practical Guide to Genes and Clinical Diagnosis 3
Biomarker-drug and liquid biopsy co-development for disease staging and targeted therapy: Cornerstones for Alzheimer’s precision medicine and pharmacology 3
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers 3
Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report 3
Commentary: Development of the Blood-Based Alzheimer's Disease Liquid Biopsy 2
Totale 2.814
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020306 0 0 0 0 21 52 62 43 47 36 34 11
2020/2021318 13 45 3 27 9 24 57 14 46 10 25 45
2021/2022350 8 7 5 13 59 47 12 14 30 22 28 105
2022/2023707 84 108 71 46 58 68 6 43 151 1 59 12
2023/2024582 45 50 49 34 79 141 31 13 5 10 51 74
2024/2025348 24 73 54 115 82 0 0 0 0 0 0 0
Totale 2.814